By admin | Published:
November 17, 2005
November 17, 2005

Catherine Demers
Recombinent human growth hormone has achieved clinical responses when used for treating heart failure. Catherine Demers of McMaster University told the American Heart Association conference about her findings.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005
By admin | Published:
November 17, 2005
November 17, 2005

Anthony Keech
Among nearly 10 000 patients with maturity onset diabetes the use of fenofibrate to lower cholesterol produced a 24 per cent statistically significant reduction of cardiovascular events, but no reduction in the risk of death. Anthony Keech of University of Sydney told AHA delegates about his findings.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005
By admin | Published:
November 17, 2005
November 17, 2005

Gunnar Gislason
As the dust continues to settle on the Vioxx issue, there is naturally a desire to look further at potential cardiovascular risks associated with COX-2 inhibitors and, indeed, other non-steroidal anti-inflammatories. Gunnar Gislason from Bispebjerg University Hospital has been leading a study aiming to look throughout Denmark for a relationship between the use of these drugs and mortality in people who have had a myocardial infarction.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005
By admin | Published:
November 17, 2005
November 17, 2005

Frans van der Werf
Near-complete data from the ASSENT-4-PCI trial investigating facilitated PCI (combining both thrombolysis and primary PCI after acute myocardial infarction) has found that PCI alone is a better choice. Frans van der Werf from the University of Leuven in Belgium.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005
Also posted in Cardiovascular | Tagged ASSENT, PCI, trial |
By admin | Published:
November 17, 2005
November 17, 2005

Olivier Bertrand
The use of abciximab perfusion after stenting was questioned at the American Heart Association meeting in Dallas. The EASY study found bolus administration of glycoprotein 2B3A inhibition was sufficient and gives the possibility of sending patients home early.Olivier Bertrand, Hôpital Laval, Quebec.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005
By admin | Published:
November 16, 2005
November 16, 2005

Milton Packer
In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005
By admin | Published:
November 16, 2005
November 16, 2005

Bryan Williams
Bryan Williams, University of Leicester
Measuring blood pressure with a cuff around the arm does not always give a clear picture of what’s happening in the aorta. The CAFE study found differences in aortic pressure lowering between regimens based on beta blockers as compared with calcium antagonists, but no differences in brachial pressure. Leicester University’s Bryan Williams told the AHA.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005
By admin | Published:
November 16, 2005
November 16, 2005

Volker Schächinger
Regeneration of the heart has been achieved by using bone-marrow derived stem cells after myocardial infarction among 200 patients. Volker Schächinger, University of Frankfurt.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005
COMMENTS
November 17, 2005
Judith Hochman from New York University told Audio Medica that patients taking aspirin need to take it half an hour before any NSAID in order to avoid drug interactions, and had these comments about the Danish study.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Click here for all the interviews from AHA 2005